...
search icon
asbp-img

Aspire BioPharma, Inc., Common Stock

ASBP

NMQ

$0.2375

+$0.01

(4.44%)

1D

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$11.90M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
843.70K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.21 L
$15.8 H
$0.2375

About Aspire BioPharma, Inc., Common Stock

Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, engages in development and marketing of disruptive technology for novel sublingual delivery mechanisms in the United States. The company offers Instaprin, a sublingual aspirin product that is a soluble, pH-neutral, fast-acting powder, which addresses cardiology emergencies and pain management. It also develops formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide. In addition, the company develops formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. Aspire Biopharma Holdings, Inc. was founded in 2021 and is based in Humacao, Puerto Rico. more

Returns

Data is not properly formatted.

Financials

Dec '22Dec '23Dec '24
Total Revenue---[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue---[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit---[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin---[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses596.49K358.59K3.09M[{"date":"2022-12-31","value":19.31,"profit":true},{"date":"2023-12-31","value":11.61,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(596.49K)(358.59K)(3.09M)[{"date":"2022-12-31","value":-59649100,"profit":false},{"date":"2023-12-31","value":-35859000,"profit":false},{"date":"2024-12-31","value":-308867100,"profit":false}]
Total Non-Operating Income/Expense--(9.79M)[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-979174900,"profit":false}]
Pre-Tax Income(596.49K)(358.59K)(12.54M)[{"date":"2022-12-31","value":-59649100,"profit":false},{"date":"2023-12-31","value":-35859000,"profit":false},{"date":"2024-12-31","value":-1253747200,"profit":false}]
Income Taxes626.00481.00-[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":76.84,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(597.12K)(359.07K)-[{"date":"2022-12-31","value":-59711700,"profit":false},{"date":"2023-12-31","value":-35907100,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(597.12K)(359.07K)(12.54M)[{"date":"2022-12-31","value":-59711700,"profit":false},{"date":"2023-12-31","value":-35907100,"profit":false},{"date":"2024-12-31","value":-1253747200,"profit":false}]
Income From Discontinued Operations---[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(597.12K)(359.07K)(12.54M)[{"date":"2022-12-31","value":-59711700,"profit":false},{"date":"2023-12-31","value":-35907100,"profit":false},{"date":"2024-12-31","value":-1253747200,"profit":false}]
EPS (Diluted)0.100.11(1.56)[{"date":"2022-12-31","value":84.89,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-1391.02,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ASBP
Current Ratio 0.22

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ASBP
ROA (LTM) 0.00%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ASBP
Debt Ratio Lower is generally better. Negative is bad. 4.54
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -3.54

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ASBP
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.00
EV/R 0.00
EV/Ebitda NM

FAQs

What is Aspire BioPharma, Inc. share price today?

Aspire BioPharma, Inc. (ASBP) share price today is $0.2375

Can Indians buy Aspire BioPharma, Inc. shares?

Yes, Indians can buy shares of Aspire BioPharma, Inc. (ASBP) on Vested. To buy Aspire BioPharma, Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ASBP stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Aspire BioPharma, Inc. be purchased?

Yes, you can purchase fractional shares of Aspire BioPharma, Inc. (ASBP) via the Vested app. You can start investing in Aspire BioPharma, Inc. (ASBP) with a minimum investment of $1.

How to invest in Aspire BioPharma, Inc. shares from India?

You can invest in shares of Aspire BioPharma, Inc. (ASBP) via Vested in three simple steps:

  • Click on Sign Up or Invest in ASBP stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Aspire BioPharma, Inc. shares
What is Aspire BioPharma, Inc. 52-week high and low stock price?

The 52-week high price of Aspire BioPharma, Inc. (ASBP) is $15.8. The 52-week low price of Aspire BioPharma, Inc. (ASBP) is $0.21.

What is Aspire BioPharma, Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Aspire BioPharma, Inc. (ASBP) is 0.00

What is the Market Cap of Aspire BioPharma, Inc.?

The market capitalization of Aspire BioPharma, Inc. (ASBP) is $11.90M

What is Aspire BioPharma, Inc.’s stock symbol?

The stock symbol (or ticker) of Aspire BioPharma, Inc. is ASBP

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top